[SDF-1/CXCR4 and multiple myeloma osteolytic bone lesions--review].
Multiple myeloma (MM) is a plasma cell malignancy characterized by the high capacity to induce bone destruction. Osteolytic bone lesions in MM patients mainly result from an increased bone resorption related to the stimulation of osteoclast recruitment and activity. SDF-1a would represent a potential role and may provide a suitable therapeutic target for MM-mediated osteolysis. In this article the structure of SDF-1/CXCR4, the expression of SDF-1/CXCR4 in bone microenvironment of MM patients and its effect on osteoclasts, relation of SDF-1/CXCR expression with osteolytic bone lesions and prognosis of MM, SDF-1/CXCR4 as potential target for treatment of myeloma-osteopathia were reviewed.
Bao
Li
L
Institute of Hematology, People Hospital, Peking University, Beijing 100044, China.
Huang
Xiao-Jun
XJ
D054377:Chemokine CXCL12 / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D009101:Multiple Myeloma / Q000150:complications* / Q000378:metabolism*; D010014:Osteolysis / Q000209:etiology*; D019718:Receptors, CXCR4 / Q000378:metabolism* / Q000502:physiology
D054377:Chemokine CXCL12; D019718:Receptors, CXCR4